Novo Nordisk (NVO)
(Delayed Data from NYSE)
$49.46 USD
-0.58 (-1.16%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $49.65 +0.19 (0.38%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Novo Nordisk A/S has a market cap of $223.43B, which represents its share price of $50.04 multiplied by its outstanding shares number of 4.47B. As a large-cap company, NVO's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NVO 49.46 -0.58(-1.16%)
Will NVO be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for NVO based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for NVO
Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
NVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings
Other News for NVO
Earnings week ahead: AMD, PLTR, PFE, O, QCOM, ENB, SHOP, MCD, UBER, SMCI, BP, LCID, MRNA, ABNB, WBD, DKNG, AMC, and more
Trending stocks this week: Wall Street extends rally on Big Tech earnings, trade optimism, Fed rate cut
What You Missed On Wall Street On Friday
Stochastic Buy Signal appears for NVO after 1.16% move
Midday Fly By: Apple, Amazon upbeat reports lift Nasdaq